Skip to main content

Share story

AI Security

Preprint proposes runtime controls for resources acquired by AI agents

Researchers describe a runtime authorization system intended to stop autonomous AI agents from turning newly acquired compute, credentials, accounts or services into unauthorized authority. The preprint's architecture quarantines returned resources, resolves their capabilities from authenticated provider evidence and activates them only after checking provenance, current authorization and limits spanning identity, effects, data and delegation. In registered evaluations, the reference implementation accepted 20 benign traces and rejected 40 unsafe traces across 810 events. A staged connection between an AI tool protocol and Docker completed two benign cases, while none of 16 unsafe cases added an unauthorized container-start request. The results remain preprint findings under explicit assumptions rather than evidence from a production deployment.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from cs.AI updates on arXiv.org and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

Security
Security

Gyazo breach exposed metadata for 490 million images

A breach at screenshot-sharing service Gyazo exposed nearly 24 million customer records and an additional 490 million image-metadata records, Infosecurity Magazine reported. Attackers exploited an upload-server vulnerability, gain...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...